Abstract:FACT (FAcilitates Chromatin Transcription) is a heterodimeric protein complex composed of SUPT16H and SSRP1, and a histone chaperone participating in chromatin remodeling during gene transcription. FACT complex is profoundly regulated, and contributes to both gene activation and suppression. Here we reported that SUPT16H, a subunit of FACT, is acetylated in both epithelial and natural killer (NK) cells. The histone acetyltransferase TIP60 contributes to the acetylation of SUPT16H middle domain (MD) at lysine 674 (K674). Such acetylation of SUPT16H is recognized by bromodomain protein BRD4, which promotes protein stability of SUPT16H in both epithelial and NK cells. We further demonstrated that SUPT16H-BRD4 associates with histone modification enzymes (HDAC1, EZH2), and further regulates their activation status and/or promoter association as well as affects the relevant histone marks (H3ac, H3K9me3 and H3K27me3). BRD4 is known to profoundly regulate interferon (IFN) signaling, while such function of SUPT16H has never been explored. Surprisingly, our results revealed that SUPT16H genetic knockdown via RNAi or pharmacological inhibition by using its inhibitor, curaxin 137 (CBL0137), results in the induction of IFNs and interferon-stimulated genes (ISGs). Through this mechanism, depletion or inhibition of SUPT16H is shown to efficiently inhibit infection of multiple viruses, including Zika, influenza, and SARS-CoV-2. Furthermore, we demonstrated that depletion or inhibition of SUPT16H also causes the remarkable activation of IFN signaling in NK cells, which promotes the NK-mediated killing of virus-infected cells in a co-culture system using human primary NK cells. Overall, our studies unraveled the previously un-appreciated role of FACT complex in coordinating with BRD4 and regulating IFN signaling in both epithelial and NK cells, and also proposed the novel application of the FACT inhibitor CBL0137 to treat viral infections.

FACT regulates pluripotency through proximal and distal regulation of gene expression in murine embryonic stem cells

CTR9/PAF1c Regulates Molecular Lineage Identity, Histone H3K36 Trimethylation and Genomic Imprinting During Preimplantation Development

Pluripotency state transition of embryonic stem cells requires the turnover of histone chaperone FACT on chromatin

Transcriptional regulation of FACT involves Coordination of chromatin accessibility and CTCF binding

FACT maintains nucleosomes during transcription and stem cell viability in adult mice

Cellular Context- and Protein Level-Dependent Interaction of Pluripotency Factor OCT4A with Multiple Octamer Motifs of the Same Target Gene

FACT Interacts with Set3 HDAC and Fine-Tunesgal1transcription in Response to Environmental Stimulation

The HMG‐box module in FACT is critical for suppressing epigenetic variegation of heterochromatin in fission yeast

FACT maintains chromatin architecture and thereby stimulates RNA polymerase II pausing during transcription in vivo

Functions of FACT in Breaking the Nucleosome and Maintaining Its Integrity at the Single-Nucleosome Level.

The FAcilitates Chromatin Transcription complex regulates the ratio of glycolysis to oxidative phosphorylation in neural stem cells

FACT modulates the conformations of histone H2A and H2B N-terminal tails within nucleosomes

SPT16 ubiquitylation by DCAF14-CRL4 regulates FACT binding to histones

FACT caught in the act of manipulating the nucleosome

The histone chaperone FACT induces Cas9 multi-turnover behavior and modifies genome manipulation in human cells

Human FACT subunits coordinate to catalyze both disassembly and reassembly of nucleosomes

The Histone Chaperone FACT Contributes to DNA Replication-Coupled Nucleosome Assembly

FACT subunit SUPT16H associates with BRD4 and contributes to silencing of interferon signaling

Zfp281 Inhibits the Pluripotent-to-Totipotent State Transition in Mouse Embryonic Stem Cells

Unwinding the Role of FACT in Cas9-based Genome Editing

Opposing functions of H2BK120 ubiquitylation and H3K79 methylation in the regulation of pluripotency by the Paf1 complex